A Phase 3 Randomized Double-blind Trial of Maintenance With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer.
Phase of Trial: Phase III
Latest Information Update: 07 Apr 2018
At a glance
- Drugs Niraparib (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Registrational; Therapeutic Use
- Acronyms NOVA
- Sponsors TESARO
- 26 Mar 2018 According to a TESARO media release, retrospective data analyses was presented in the plenary session at the 2018 Society for Gynecologic Oncology (SGO) Annual Meeting on Sunday, March 25.
- 26 Mar 2018 Results presented in the TESARO media release.
- 27 Feb 2018 According to a TESARO media release, a retrospective, exploratory analysis of this trial, was presented as part of a Satellite Symposium at the International Meeting of the European Society of Gynaecological Oncology (ESGO) in November 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History